At Abyssinia we're transforming the world's understanding of Alzheimer's Disease, from diagnostic assays that detect early onset, to treatment paradigms targeting novel disease drivers. Our mission is to disrupt every point in the Alzheimer's patient journey and raise the standard of living for Alzheimer's patients around the globe. -For licensing or investor inquiries please contact opportunities@aby-bio.com